|
|
Always |
Sometimes Never |
|
MCDA matrix criteria |
|
|
|
|
|
Quality of evidence |
|
|
|
|
|
Adherence to requirements of decision making body |
9 |
33 |
67 |
0 |
|
Completeness and consistency of reporting evidence |
9 |
89 |
11 |
0 |
|
Relevance and validity of evidence |
9 |
89 |
11 |
0 |
|
Disease impact |
|
|
|
|
|
Disease severity |
9 |
89 |
11 |
0 |
|
Size of population affected by disease |
9 |
67 |
33 |
0 |
|
Intervention |
|
|
|
|
|
Current clinical guidelines |
9 |
89 |
11 |
0 |
|
Current interventions limitations |
9 |
78 |
22 |
0 |
|
Improvement of efficacy/effectiveness |
9 |
89 |
11 |
0 |
|
Improvement of safety & tolerability |
9 |
78 |
22 |
0 |
|
Improvement of PRO, convenience & adherence |
9 |
44 |
56 |
0 |
|
Public health interest (prevention & risk reduction) |
9 |
78 |
22 |
0 |
|
Type of medical service |
9 |
89 |
11 |
0 |
|
Economics |
|
|
|
|
|
Budget impact on health plan |
9 |
100 |
0 |
0 |
|
Cost-effectiveness of intervention |
9 |
89 |
11 |
0 |
|
Impact on other spending |
9 |
78 |
22 |
0 |
|
Other criteria |
|
|
|
|
|
Appropriate use |
9 |
89 |
11 |
0 |
|
Opportunity costs |
9 |
78 |
22 |
0 |
|
Organizational structure |
9 |
22 |
78 |
0 |
|
Stakeholder pressures |
9 |
33 |
67 |
0 |
|
Political context |
9 |
11 |
89 |
0 |
|
Population priorities and access |
9 |
22 |
78 |
0 |
|
Regulatory status of intervention |
9 |
56 |
44 |
0 |